Peripheral mechanisms of pain and analgesia

[1]  S. Snyder,et al.  Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section , 1976, Brain Research.

[2]  S. Ferreira,et al.  I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. , 1979, Prostaglandins.

[3]  A. Takemori,et al.  Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. , 1979, The Journal of pharmacology and experimental therapeutics.

[4]  L. Iversen,et al.  Multiple opiate receptor sites on primary afferent fibres , 1980, Nature.

[5]  A. Takemori,et al.  Interactions of leucine enkephalin and narcotics with opioid receptors. , 1981, Molecular pharmacology.

[6]  J. Willer,et al.  Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. , 1981, Science.

[7]  G. Wilcox,et al.  Intrathecal opioids block a spinal action of substance P in mice: Functional importance of both μ- and δ-receptors , 1982 .

[8]  A. Takemori,et al.  Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. , 1983, The Journal of pharmacology and experimental therapeutics.

[9]  R. Przewłocki,et al.  Characterization and localization of immunoreactive dynorphin, α-neo-endorphin, met-enkephalin and substance P in human spinal cord , 1983, Brain Research.

[10]  Y. Shavit,et al.  Intrinsic mechanisms of pain inhibition: activation by stress. , 1984, Science.

[11]  R. Saunders,et al.  Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Weihe,et al.  Prodynorphin opioid peptides in small somatosensory primary afferents of guinea pig , 1985, Neuroscience Letters.

[13]  B. Roth,et al.  Differential ontogeny of multiple opioid receptors (mu, delta, and kappa) , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  J. Neale,et al.  Localization of dynorphin gene product-immunoreactivity in neurons from spinal cord and dorsal root ganglia , 1986, Neuroscience.

[15]  A. Dickenson,et al.  Alpha 2-adrenoceptor modulation of nociception in rat spinal cord: location, effects and interactions with morphine. , 1987, European journal of pharmacology.

[16]  G. Aghajanian,et al.  Common α2- and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices , 1987, Neuropharmacology.

[17]  D. L. Larson,et al.  Hybrid bivalent ligands with opiate and enkephalin pharmacophores. , 1987, Journal of medicinal chemistry.

[18]  G. Wilcox,et al.  Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord , 1987, Brain Research.

[19]  B. Dvorkin,et al.  Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin , 1988, Brain Research.

[20]  B. Meyerson,et al.  Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain , 1988, Pain.

[21]  T. Yaksh,et al.  Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies. , 1988, The Journal of pharmacology and experimental therapeutics.

[22]  T. Yaksh.  Substance P release from knee joint afferent terminals: modulation by opioids , 1988, Brain Research.

[23]  A. Spiegel,et al.  G proteins couple alpha-adrenergic and GABAb receptors to inhibition of peptide secretion from peripheral sensory neurons , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  J. Eisenach,et al.  Epidural clonidine analgesia for intractable cancer pain: phase I. , 1989, Anesthesiology.

[25]  S. Childers,et al.  Modification of Gs‐Stimulated Adenylate Cyclase in Brain Membranes by Low pH Pretreatment: Correlation with Altered Guanine Nucleotide Exchange , 1988, Journal of neurochemistry.

[26]  R. Dubner,et al.  Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. , 1989, European journal of pharmacology.

[27]  T. Shippenberg,et al.  Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. , 1989, The Journal of pharmacology and experimental therapeutics.

[28]  A. Harmar,et al.  Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons , 1989, Nature.

[29]  A. Kavelaars,et al.  In Vitro β-Adrenergic Stimulation of Lymphocytes Induces the Release of Immunoreactive β-Endorphin , 1990 .

[30]  A. Zinsmeister,et al.  Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. , 1990, The Journal of pharmacology and experimental therapeutics.

[31]  H O Handwerker,et al.  Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region. , 1990, The Journal of investigative dermatology.

[32]  M. Ossipov,et al.  Antinociceptive interaction between opioids and medetomidine: systemic additivity and spinal synergy. , 1990, Anesthesiology.

[33]  R.A. LSHEEHAN‐DARE,et al.  Anxiety and depression in patients with chronic urticaria and generalized pruritus , 1990, The British journal of dermatology.

[34]  A. Herz,et al.  Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  K. Omote,et al.  The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats. , 1990, Anesthesia and analgesia.

[36]  M. Ossipov,et al.  An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates. , 1990, The Journal of pharmacology and experimental therapeutics.

[37]  M. Ossipov,et al.  Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: isobolographic analysis. , 1990, Life sciences.

[38]  R. Przewłocki,et al.  Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Handwerker,et al.  Discharge patterns of human C-fibers induced by itching and burning stimuli. , 1991, Journal of neurophysiology.

[40]  A. Herz,et al.  Analgesic effect of intraarticular morphine after arthroscopic knee surgery. , 1991, The New England journal of medicine.

[41]  W. Mobley,et al.  Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Wilcox,et al.  Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors. , 1992, The Journal of pharmacology and experimental therapeutics.

[43]  W. Bowen,et al.  Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. , 1992, The Journal of pharmacology and experimental therapeutics.

[44]  A. Malmberg,et al.  Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. , 1992, Science.

[45]  P. Ernfors,et al.  Colocalization of NGF binding sites, trk mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  R. Edwards,et al.  Cloning of a delta opioid receptor by functional expression. , 1992, Science.

[47]  R. Przewłocki,et al.  Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception , 1992, Neuroscience.

[48]  P. Akins,et al.  Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP , 1993, Neuroscience.

[49]  H. Loh,et al.  Immunofluorescent identification of a delta (delta)-opioid receptor on primary afferent nerve terminals. , 1993, Neuroreport.

[50]  G. Uhl,et al.  mu opiate receptor: cDNA cloning and expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[51]  A Goldstein,et al.  Cloning and pharmacological characterization of a rat kappa opioid receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Local analgesic effect of endogenous opioid peptides , 1993, The Lancet.

[53]  D. Selley,et al.  Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. , 1993, Molecular pharmacology.

[54]  A. Herz,et al.  Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. , 1993, European journal of pharmacology.

[55]  A. Herz,et al.  Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue , 1993, Neuroscience.

[56]  M. Hamon,et al.  Expression of Preproenkephalin A Gene and Presence of Met‐Enkephalin in Dorsal Root Ganglia of the Adult Rat , 1994, Journal of neurochemistry.

[57]  M. Quartu,et al.  Enkephalins occur and colocalize with substance P in human trigeminal ganglion neurones. , 1994, Neuroreport.

[58]  C. Stein,et al.  Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Burnstock,et al.  Neuropeptide‐containing nerves in painful hypertrophic human scar tissue , 1994, The British journal of dermatology.

[60]  J. A. Spitzer,et al.  Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages Parallel changes with proenkephalin-derived peptides induced by LPS in vivo , 1994, Neuropeptides.

[61]  C. Woolf,et al.  Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity , 1994, Neuroscience.

[62]  J. Eisenach,et al.  An isobolographic study of epidural clonidine and fentanyl after cesarean section. , 1994, Anesthesia and analgesia.

[63]  S. Rutkowski,et al.  Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report , 1994, Pain.

[64]  H. Akil,et al.  Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study , 1994, The Journal of comparative neurology.

[65]  L. Mendell,et al.  Peripheral and Central Mechanisms of NGF‐induced Hyperalgesia , 1994, The European journal of neuroscience.

[66]  K. Befort,et al.  The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Dobrowsky,et al.  Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. , 1994, Science.

[68]  John T. Williams,et al.  Opioid inhibition of Ih via adenylyl cyclase , 1994, Neuron.

[69]  S. McMahon,et al.  Immunocytochemical Localization of trkA Receptors in Chemically Identified Subgroups of Adult Rat Sensory Neurons , 1995, The European journal of neuroscience.

[70]  F. Porreca,et al.  Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. , 1995, The Journal of pharmacology and experimental therapeutics.

[71]  J. Maloteaux,et al.  Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P , 1995, Neuroscience.

[72]  M. Minami,et al.  Double in situ hybridization study on coexistence of μ-, δ- and κ-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia , 1995 .

[73]  S. McMahon,et al.  The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule , 1995, Nature Medicine.

[74]  M. Vasko,et al.  Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  J. Levine,et al.  Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[76]  C. Stein,et al.  Perineurial defect and peripheral opioid analgesia in inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[77]  J. Eisenach,et al.  Epidural clonidine analgesia for intractable cancer pain , 1995, Pain.

[78]  P. Law,et al.  Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[79]  H. Loh,et al.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[80]  C. Stein.  The control of pain in peripheral tissue by opioids. , 1995, The New England journal of medicine.

[81]  M. Scheinin,et al.  Molecular pharmacology of α2-adrenoceptor subtypes , 1995 .

[82]  Timothy J. Brennan,et al.  Characterization of a rat model of incisional pain , 1996, Pain.

[83]  C. Stein,et al.  Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Besson,et al.  To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study. , 1996, The Journal of pharmacology and experimental therapeutics.

[85]  T. Kaneko,et al.  Effects of peripheral nerve ligation on expression of μ-opioid receptor in sensory ganglion neurons: an immunohistochemical study in dorsal root and nodose ganglion neurons of the rat , 1996, Neuroscience Letters.

[86]  S. McMahon.  NGF as a mediator of inflammatory pain. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[87]  A. Hassan,et al.  Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. , 1996, European journal of pharmacology.

[88]  L. Mendell,et al.  Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. , 1996, Journal of neurophysiology.

[89]  M. von Zastrow,et al.  Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Vasko,et al.  Activation of Protein Kinase C Augments Peptide Release from Rat Sensory Neurons , 1996, Journal of neurochemistry.

[91]  A. Hassan,et al.  No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. , 1996, The Journal of clinical investigation.

[92]  J. Levine,et al.  DAMGO inhibits prostaglandin E2-induced potentiation of a TTX-resistant Na+ current in rat sensory neurons in vitro , 1996, Neuroscience Letters.

[93]  S. Skaper,et al.  Nerve growth factor: from neurotrophin to neurokine , 1996, Trends in Neurosciences.

[94]  K. Mackie,et al.  Modulation of Ca2+ channels βγ G-protein py subunits , 1996, Nature.

[95]  R. Amann,et al.  Intraplantar injection of nerve growth factor into the rat hind paw: local edema and effects on thermal nociceptive threshold , 1996, Pain.

[96]  D. Kim,et al.  Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[97]  C. Woolf,et al.  Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  O. Simell,et al.  Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice. , 1996, Blood.

[99]  K. J. Oswald,et al.  Alpha 2A-adrenergic receptor stimulated calcium release is transduced by Gi-associated G(beta gamma)-mediated activation of phospholipase C. , 1997, Biochemistry.

[100]  Hermann O. Handwerker,et al.  Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.

[101]  R. Coggeshall,et al.  Immunohistochemical localization of enkephalin in peripheral sensory axons in the rat , 1997, Neuroscience Letters.

[102]  V. Pickel,et al.  Dual ultrastructural immunocytochemical labeling of μ and δ opioid receptors in the superficial layers of the rat cervical spinal cord , 1997, Brain Research.

[103]  H. Handwerker,et al.  Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis , 1997, Pain.

[104]  C. Woolf,et al.  The progressive tactile hyperalgesia induced by peripheral inflammation is nerve growth factor dependent , 1997, Neuroreport.

[105]  J. Wood,et al.  Chemical activators of sensory neurons. , 1997, Annual review of physiology.

[106]  D. Steiner,et al.  Expression of PC3, carboxypeptidase E and enkephalin in human monocyte‐derived macrophages as a tool for genetic studies , 1997, FEBS letters.

[107]  T. Hökfelt,et al.  Peptide plasticity in primary sensory neurons and spinal cord during adjuvant-induced arthritis in the rat: an immunocytochemical and in situ hybridization study , 1997, Neuroscience.

[108]  B. Cox,et al.  Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction , 1997, Neuroscience.

[109]  T. Brennan,et al.  Effect of Systemic and Intrathecal Morphine in a Rat Model of Postoperative Pain , 1997, Anesthesiology.

[110]  J. Levine,et al.  Different Mechanisms Mediate Development and Expression of Tolerance and Dependence for Peripheral μ-Opioid Antinociception in Rat , 1997, The Journal of Neuroscience.

[111]  D. Julius,et al.  The capsaicin receptor: a heat-activated ion channel in the pain pathway , 1997, Nature.

[112]  J. J. Chen,et al.  Regulation of opioid receptors in rat sensory neurons in culture. , 1997, Molecular pharmacology.

[113]  R. Coggeshall,et al.  Opioid receptors on peripheral sensory axons , 1997, Brain Research.

[114]  G. Bernatzky,et al.  Intraarticular Morphine Analgesia in Chronic Pain Patients with Osteoarthritis , 1997, Anesthesia and analgesia.

[115]  M. Scheinin,et al.  Gene targeting — homing in on α2-adrenoceptor-subtype function , 1997 .

[116]  T. Hökfelt,et al.  Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles , 1997, Neuroscience.

[117]  M. Hashiro,et al.  Anxiety, depression and psychosomatic symptoms in patients with atopic dermatitis: comparison with normal controls and among groups of different degrees of severity. , 1997, Journal of dermatological science.

[118]  M. Tramèr,et al.  Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials , 1997, Pain.

[119]  J. Loeffler,et al.  Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. , 1997, The Journal of clinical investigation.

[120]  T. Hökfelt,et al.  Down-regulation of μ-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy , 1997, Neuroscience.

[121]  M. Murakami,et al.  Cyclooxygenase-2-dependent delayed prostaglandin D2 generation is initiated by nerve growth factor in rat peritoneal mast cells: its augmentation by extracellular type II secretory phospholipase A2. , 1997, Journal of immunology.

[122]  J. Blalock,et al.  Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes , 1997, Journal of Neuroimmunology.

[123]  L. Stone,et al.  The α2a Adrenergic Receptor Subtype Mediates Spinal Analgesia Evoked by α2 Agonists and Is Necessary for Spinal Adrenergic–Opioid Synergy , 1997, The Journal of Neuroscience.

[124]  E. Bröcker,et al.  Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. , 1998, The American journal of pathology.

[125]  J. Pintar,et al.  Developmental Expression of the μ, κ, and δ Opioid Receptor mRNAs in Mouse , 1998, The Journal of Neuroscience.

[126]  M. Wessendorf,et al.  Immunoreactivity for endomorphin‐2 occurs in primary afferents in rats and monkey , 1998, Neuroreport.

[127]  J. Lopshire,et al.  The cAMP Transduction Cascade Mediates the Prostaglandin E2 Enhancement of the Capsaicin-Elicited Current in Rat Sensory Neurons: Whole-Cell and Single-Channel Studies , 1998, The Journal of Neuroscience.

[128]  R. Elde,et al.  Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia , 1998, Neuroscience.

[129]  A. Wittinghofer,et al.  Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP , 1998, Nature.

[130]  P. Cabot,et al.  Pain control in inflammation governed by selectins , 1998, Nature Medicine.

[131]  T. Kaneko,et al.  Immunocytochemical localization of μ-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat , 1998, Brain Research.

[132]  T. Hökfelt,et al.  Differential Distribution of a 2 A and a 2 C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord , 1998 .

[133]  R. Shigemoto,et al.  GABAB-receptor subtypes assemble into functional heteromeric complexes , 1998, Nature.

[134]  Q. Zhang,et al.  Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. , 1998, The Journal of pharmacology and experimental therapeutics.

[135]  A. Kastin,et al.  Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers , 1998, Peptides.

[136]  M. Koltzenburg,et al.  Nerve growth factor regulates the expression of bradykinin binding sites on adult sensory neurons via the neurotrophin receptor p75 , 1998, Neuroscience.

[137]  T. Hökfelt,et al.  Differential Distribution of α2A and α2C Adrenergic Receptor Immunoreactivity in the Rat Spinal Cord , 1998, The Journal of Neuroscience.

[138]  S. Waxman,et al.  Sodium channel expression in NGF‐overexpressing transgenic mice , 1999, Journal of neuroscience research.

[139]  L. Mendell,et al.  Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin , 1999, Neuroscience Letters.

[140]  C. Stein,et al.  Intraarticular morphine versus dexamethasone in chronic arthritis , 1999, PAIN®.

[141]  C. Stein,et al.  Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. , 1999, The Journal of pharmacology and experimental therapeutics.

[142]  C. N. Honda,et al.  Immunohistochemical localization of delta opioid receptors in peripheral tissues , 1999, The Journal of comparative neurology.

[143]  H. Loh,et al.  δ-opioid-induced liberation of Gβγ mobilizes Ca2+ stores in NG108- 15 cells , 1999 .

[144]  M. Millan,et al.  The induction of pain: an integrative review , 1999, Progress in Neurobiology.

[145]  D. Julius,et al.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide , 1999, Nature.

[146]  A. Zimmer,et al.  Preproenkephalin is a Th2 cytokine but is not required for Th2 differentiation in vitro , 1999, Immunology and cell biology.

[147]  J. Bienenstock,et al.  Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. , 1999, Journal of immunology.

[148]  Ji Ming Wang,et al.  Inhibition of chemokine-induced chemotaxis of monkey leukocytes by mu-opioid receptor agonists. , 1999, In vivo.

[149]  M. Connor,et al.  OPIOID RECEPTOR SIGNALLING MECHANISMS , 1999, Clinical and experimental pharmacology & physiology.

[150]  Vicki Brower,et al.  New paths to pain relief , 2000, Nature Biotechnology.

[151]  C. Mackay,et al.  T-cell function and migration. Two sides of the same coin. , 2000, The New England journal of medicine.

[152]  S. Bingham,et al.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia , 2000, Nature.

[153]  J. Levine,et al.  Chronic Hypersensitivity For Inflammatory Nociceptor Sensitization Mediated by the ε Isozyme of Protein Kinase C , 2000, The Journal of Neuroscience.

[154]  F. Cunha,et al.  Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonist , 2000, British journal of pharmacology.

[155]  L. Stone,et al.  Moxonidine, a selective imidazoline/α 2 adrenergic receptor agonist, synergizes with morphine and deltorphin II to inhibit substance P-induced behavior in mice , 2000, Pain.

[156]  H. Loh,et al.  Molecular mechanisms and regulation of opioid receptor signaling. , 2000, Annual review of pharmacology and toxicology.

[157]  H. Loh,et al.  Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury , 2000, Neuroscience Letters.

[158]  J. Wang,et al.  Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. , 2000, Immunopharmacology.

[159]  C. Woolf,et al.  Neuronal plasticity: increasing the gain in pain. , 2000, Science.

[160]  C. Stein,et al.  Co-expression of β-endorphin with adhesion molecules in a model of inflammatory pain , 2000, Journal of Neuroimmunology.

[161]  K. Peter,et al.  Continuous axillary brachial plexus analgesia with low dose morphine in patients with complex regional pain syndromes. , 2000, European journal of anaesthesiology.

[162]  S. McMahon,et al.  Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord , 2000, The European journal of neuroscience.

[163]  S. Hwang,et al.  Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[164]  A I Basbaum,et al.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor. , 2000, Science.

[165]  D. Hammond,et al.  Synergistic interactions between two α 2-adrenoceptor agonists, dexmedetomidine and ST-91, in two substrains of Sprague–Dawley rats , 2000, Pain.

[166]  A. Craig,et al.  Spinothalamic lamina I neurones selectively responsive to cutaneous warming in cats , 2001, The Journal of physiology.

[167]  C. Stein,et al.  Peripheral analgesic and antiinflammatory effects of opioids , 2001, Zeitschrift für Rheumatologie.

[168]  M. Angst,et al.  Opioid-Induced Hyperalgesia and Incisional Pain , 2001, Anesthesia and analgesia.

[169]  R. Ji,et al.  β-Endorphin-containing memory-cells and μ-opioid receptors undergo transport to peripheral inflamed tissue , 2001, Journal of Neuroimmunology.

[170]  D. Simone,et al.  Peripheral and preemptive opioid antinociception in a mouse visceral pain model , 2001, Pain.

[171]  R J Miller,et al.  Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.

[172]  S. Gordon,et al.  Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation , 2001, Clinical pharmacology and therapeutics.

[173]  A. Beaudet,et al.  Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: Evidence for somatodendritic labeling and antigen‐specific cellular compartmentalization , 2001, The Journal of comparative neurology.

[174]  L. Mendell,et al.  Acute sensitization by NGF of the response of small-diameter sensory neurons to capsaicin. , 2001, Journal of neurophysiology.

[175]  J. Kraus,et al.  Regulation of μ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site* , 2001, The Journal of Biological Chemistry.

[176]  M. Southall,et al.  Prostaglandin Receptor Subtypes, EP3C and EP4, Mediate the Prostaglandin E2-induced cAMP Production and Sensitization of Sensory Neurons* , 2001, The Journal of Biological Chemistry.

[177]  A. Moriondo,et al.  Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide , 2001, The Journal of physiology.

[178]  Huan Wang,et al.  Equal proportions of small and large DRG neurons express opioid receptor mRNAs , 2001, The Journal of comparative neurology.

[179]  M. Fitzgerald,et al.  Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats , 2001, Pain.

[180]  S. McMahon,et al.  Nerve growth factor induces P2X3 expression in sensory neurons , 2001, Journal of neurochemistry.

[181]  D. Lysle,et al.  Morphine modulation of the contact hypersensitivity response: characterization of immunological changes. , 2001, Clinical immunology.

[182]  P. Cabot,et al.  Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain , 2001, Pain.

[183]  H. Rittner,et al.  Opioid Peptide–expressing Leukocytes: Identification, Recruitment, and Simultaneously Increasing Inhibition of Inflammatory Pain , 2001, Anesthesiology.

[184]  H. Junger,et al.  Effects of full-thickness burns on nociceptor sensitization in anesthetized rats. , 2002, Burns : journal of the International Society for Burn Injuries.

[185]  M. von Zastrow,et al.  Modulation of Postendocytic Sorting of G Protein-Coupled Receptors , 2002, Science.

[186]  M. Millan.  Descending control of pain , 2002, Progress in Neurobiology.

[187]  S. Hwang,et al.  Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[188]  H. Shannon,et al.  Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats , 2002, Neuropharmacology.

[189]  J. Deleo,et al.  The Role of Spinal Neuroimmune Activation in Morphine Tolerance/Hyperalgesia in Neuropathic and Sham-Operated Rats , 2002, The Journal of Neuroscience.

[190]  C. Stein,et al.  Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain , 2002, Journal of Neuroimmunology.

[191]  T. Vanderah,et al.  Sustained Morphine Exposure Induces a Spinal Dynorphin-Dependent Enhancement of Excitatory Transmitter Release from Primary Afferent Fibers , 2002, The Journal of Neuroscience.

[192]  J. Glorioso,et al.  Targeted gene delivery to the nervous system using herpes simplex virus vectors , 2002, Physiology & Behavior.

[193]  E. Kalso,et al.  No pain, no gain: clinical excellence and scientific rigour – lessons learned from IA morphine , 2002, Pain.

[194]  H. Rittner,et al.  Opioid Control of Inflammatory Pain Regulated by Intercellular Adhesion Molecule-1 , 2002, The Journal of Neuroscience.

[195]  C. Woolf,et al.  p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.

[196]  M. Southall,et al.  Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE2-mediated sensitization of rat sensory neurons , 2002, Pain.

[197]  C. Gaveriaux-Ruff,et al.  Exploring the opioid system by gene knockout , 2002, Progress in Neurobiology.

[198]  M. Brede,et al.  Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[199]  M. Adler,et al.  Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[200]  C. Svensson,et al.  The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. , 2002, Annual review of pharmacology and toxicology.

[201]  R. Schulz,et al.  Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization , 2002, The Journal of Neuroscience.

[202]  M. Gunzer,et al.  Localization of μ-opioid receptor 1A on sensory nerve fibers in human skin , 2002, Regulatory Peptides.

[203]  L. Stone,et al.  alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy. , 2002, The Journal of pharmacology and experimental therapeutics.

[204]  John E. Murphy,et al.  Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury , 2003, Nature Medicine.

[205]  L. Klesse,et al.  Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors , 2003, Molecular and Cellular Neuroscience.

[206]  M. Welte,et al.  Modulation of Peripheral Endogenous Opioid Analgesia by Central Afferent Blockade , 2003, Anesthesiology.

[207]  Eric M. Smith,et al.  Opioid peptides in immune cells. , 2003, Advances in experimental medicine and biology.

[208]  Jörn Lötsch,et al.  Peripheral opioid analgesia in experimental human pain models. , 2003, Brain : a journal of neurology.

[209]  M. Hamon,et al.  Gene therapy of chronic pain. , 2003, Current gene therapy.

[210]  M. Chao,et al.  Neurotrophins and their receptors: A convergence point for many signalling pathways , 2003, Nature Reviews Neuroscience.

[211]  D. Zochodne,et al.  μ Opioid receptors and analgesia at the site of a peripheral nerve injury , 2003 .

[212]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[213]  C. Stein,et al.  Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. , 2003, Molecular pharmacology.

[214]  W. Swaim,et al.  Immunohistochemical localization of mu-opioid receptors in human dental pulp. , 2003, Journal of endodontics.

[215]  S. Raja,et al.  A Mouse Model of Incisional Pain , 2003, Anesthesiology.

[216]  T. Hökfelt,et al.  Activation of Delta Opioid Receptors Induces Receptor Insertion and Neuropeptide Secretion , 2003, Neuron.

[217]  J. Eisenach,et al.  Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis , 2003, Pain.

[218]  L. Devi,et al.  Functional interactions between mu opioid and alpha 2A-adrenergic receptors. , 2003, Molecular pharmacology.

[219]  L. Mendell,et al.  Mechanisms of sensitization of the response of single dorsal root ganglion cells from adult rat to noxious heat , 2003, The European journal of neuroscience.

[220]  F. Cunha,et al.  Peripheral hyperalgesic cytokines. , 2003, Advances in experimental medicine and biology.

[221]  J. Sawynok.  Topical and Peripherally Acting Analgesics , 2003, Pharmacological Reviews.

[222]  C. Stein,et al.  Different mechanisms of intrinsic pain inhibition in early and late inflammation , 2003, Journal of Neuroimmunology.

[223]  D. Zochodne,et al.  Mu opioid receptors and analgesia at the site of a peripheral nerve injury. , 2003, Annals of neurology.

[224]  E. Mccleskey,et al.  Quantitative Single-Cell Differences in μ-Opioid Receptor mRNA Distinguish Myelinated and Unmyelinated Nociceptors , 2003, The Journal of Neuroscience.

[225]  C. Stein,et al.  Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain , 2003, Pain.

[226]  J. McArthur,et al.  New insights into diabetic polyneuropathy. , 2003, JAMA.

[227]  C. Gaveriaux-Ruff,et al.  Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. , 2003, The Journal of clinical investigation.

[228]  C. Stein,et al.  Attacking pain at its source: new perspectives on opioids , 2003, Nature Medicine.

[229]  P. McNaughton,et al.  Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor , 2003, The Journal of physiology.

[230]  A. Beaudet,et al.  Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia , 2003, The Journal of comparative neurology.

[231]  T. Kaneko,et al.  Expression and G-protein coupling of μ-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats , 2003, Neuropeptides.

[232]  H O Handwerker,et al.  Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. , 2003, Journal of neurophysiology.

[233]  P. Rivière.  Peripheral kappa‐opioid agonists for visceral pain , 2004, British journal of pharmacology.

[234]  R. Reszka,et al.  Tissue Monocytes/Macrophages in Inflammation: Hyperalgesia versus Opioid-mediated Peripheral Antinociception , 2004, Anesthesiology.

[235]  M. Costa,et al.  Pathway-specific patterns of the co-existence of substance P, calcitonin gene-related peptide, cholecystokinin and dynorphin in neurons of the dorsal root ganglia of the guinea-pig , 1987, Cell and Tissue Research.

[236]  M. Shakibaei,et al.  Subcellular Pathways of β-Endorphin Synthesis, Processing, and Release from Immunocytes in Inflammatory Pain , 2004 .

[237]  S. Maier,et al.  A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine , 2004, The Journal of Neuroscience.

[238]  G. Geisslinger,et al.  Opioids As Modulators of Cell Death and Survival—Unraveling Mechanisms and Revealing New Indications , 2004, Pharmacological Reviews.

[239]  P. Cabot,et al.  Reduction of &bgr;-Endorphin-Containing Immune Cells in Inflamed Paw Tissue Corresponds with a Reduction in Immune-Derived Antinociception: Reversible by Donor Activated Lymphocytes , 2004, Anesthesia and analgesia.

[240]  K. Valentino,et al.  Ultrastructural studies on calcitonin gene-related peptide-, tachykinins- and somatostatin-immunoreactive neurones in rat dorsal root ganglia: Evidence for the colocalization of different peptides in single secretory granules , 1988, Cell and Tissue Research.

[241]  H. Rittner,et al.  Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells , 2004, Pain.

[242]  A. Ahmadiani,et al.  Involvement of Interleukin‐1β in Systemic Morphine Effects on Paw Oedema in a Mouse Model of Acute Inflammation , 2004, Scandinavian journal of immunology.

[243]  L. Stone,et al.  Alpha-2-adrenergic and opioid receptor additivity in rat locuscoeruleus neurons , 2004, Neuroscience Letters.

[244]  D. Clapham,et al.  Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.

[245]  H. Ueda,et al.  Loss of Peripheral Morphine Analgesia Contributes to the Reduced Effectiveness of Systemic Morphine in Neuropathic Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.

[246]  Y. H. Zhang,et al.  NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor , 2004, Neuroscience Letters.

[247]  L. Stone,et al.  Alpha-2-adrenergic and opioid receptor additivity in rat locus coeruleus neurons. , 2004, Neuroscience letters.

[248]  R. Rush,et al.  Elevated Nerve Growth Factor Levels in the Synovial Fluid of Patients with Inflammatory Joint Disease , 1998, Neurochemical Research.

[249]  C. Stein,et al.  Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue , 2004, The European journal of neuroscience.

[250]  V. Di Marzo,et al.  Actions of two naturally occurring saturated N‐acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels , 2004, British journal of pharmacology.

[251]  R. Likar,et al.  Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia. , 2004, British journal of anaesthesia.

[252]  A. Herz,et al.  Involvement of capsaicin-sensitive neurones in hyperalgesia and enhanced opioid antinociception in inflammation , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

[253]  P. Rivière,et al.  FE200041 (d-Phe-d-Phe-d-Nle-d-Arg-NH2): A Peripheral Efficacious κ Opioid Agonist with Unprecedented Selectivity , 2004, Journal of Pharmacology and Experimental Therapeutics.

[254]  D. Weinreich,et al.  Bradykinin decreases K+ and increases Cl− conductances in vagal afferent neurones of the guinea pig , 2004, The Journal of physiology.

[255]  C. Stein,et al.  Characterization of μ Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.

[256]  A. Brack,et al.  Rapid upregulation of μ opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction , 2004, Neuroscience.

[257]  H. Rittner,et al.  Selectins and integrins but not platelet–endothelial cell adhesion molecule‐1 regulate opioid inhibition of inflammatory pain , 2004, British journal of pharmacology.

[258]  R. Dolle,et al.  Peripherally restricted opioid agonists as novel analgesic agents. , 2004, Current pharmaceutical design.

[259]  H. Rittner,et al.  Mobilization of Opioid-containing Polymorphonuclear Cells by Hematopoietic Growth Factors and Influence on Inflammatory Pain , 2004, Anesthesiology.

[260]  R. Przewłocki,et al.  Peripheral versus Central Antinociceptive Actions of 6-Amino Acid-Substituted Derivatives of 14-O-Methyloxymorphone in Acute and Inflammatory Pain in the Rat , 2005, Journal of Pharmacology and Experimental Therapeutics.

[261]  David J. Daniels,et al.  Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[262]  F. Cunha,et al.  Nociceptive Effect of Subcutaneously Injected Interleukin-12 Is Mediated by Endothelin (ET) Acting on ETB Receptors in Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[263]  Y. Hannun,et al.  The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate , 2005, Molecular Pharmacology.

[264]  F. Leblond,et al.  Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain , 2005, Neuroscience.

[265]  M. Banck,et al.  Intrathecal gene transfer by adeno-associated virus for pain. , 2005, Current opinion in molecular therapeutics.

[266]  B. Plytycz,et al.  Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice. , 2005, Immunology letters.

[267]  M. Fung,et al.  Randomized, Double-blind Study of the Analgesic Efficacy of Morphine-6-Glucuronide versus Morphine Sulfate for Postoperative Pain in Major Surgery , 2005, Anesthesiology.

[268]  F. Cunha,et al.  A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[269]  K. K. Rau,et al.  Diverse immunocytochemical expression of opioid receptors in electrophysiologically defined cells of rat dorsal root ganglia , 2005, Journal of Chemical Neuroanatomy.

[270]  P. McNaughton,et al.  NGF rapidly increases membrane expression of TRPV1 heat‐gated ion channels , 2005, The EMBO journal.

[271]  F. Rice,et al.  CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[272]  S. Schulz,et al.  Receptor Endocytosis Counteracts the Development of Opioid Tolerance , 2005, Molecular Pharmacology.

[273]  J. Levine,et al.  Epac Mediates a cAMP-to-PKC Signaling in Inflammatory Pain: An Isolectin B4(+) Neuron-Specific Mechanism , 2005, The Journal of Neuroscience.

[274]  B. Song,et al.  Inhibition by Spinal μ- and δ-Opioid Agonists of Afferent-Evoked Substance P Release , 2005, The Journal of Neuroscience.

[275]  T. Brennan,et al.  Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia , 2005, Pain.

[276]  O. Krishtal,et al.  Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism , 2005, Neuropharmacology.

[277]  Sabita Roy,et al.  Morphine Impairs Host Innate Immune Response and Increases Susceptibility to Streptococcus pneumoniae Lung Infection1 , 2005, The Journal of Immunology.

[278]  K. Hargreaves,et al.  Bradykinin-Induced Functional Competence and Trafficking of the δ-Opioid Receptor in Trigeminal Nociceptors , 2005, The Journal of Neuroscience.

[279]  A. Lastra,et al.  Effects of the local administration of selective μ-, δ-and κ-opioid receptor agonists on osteosarcoma-induced hyperalgesia , 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

[280]  U. Oh.  Chapter 5 Nociceptive Signals to TRPV1 and its Clinical Potential , 2006 .

[281]  Martin S. Angst,et al.  Opioid-induced Hyperalgesia: A Qualitative Systematic Review , 2006, Anesthesiology.

[282]  I. Bileviciute-Ljungar,et al.  Peripherally Mediated Antinociception of the μ-Opioid Receptor Agonist 2-[(4,5α-Epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[283]  M. Angst,et al.  Blockade of the Complement C5a Receptor Reduces Incisional Allodynia, Edema, and Cytokine Expression , 2006, Anesthesiology.

[284]  F. Liew,et al.  IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[285]  T. Jessell,et al.  Runx1 Determines Nociceptive Sensory Neuron Phenotype and Is Required for Thermal and Neuropathic Pain , 2006, Neuron.

[286]  A. Kreicbergs,et al.  Opioid peptides and receptors in joint tissues: Study in the rat , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[287]  W. Bowles,et al.  Chronic nerve growth factor administration increases the peripheral exocytotic activity of capsaicin-sensitive cutaneous neurons , 2006, Neuroscience Letters.

[288]  O. Valverde,et al.  Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain , 2006, Neuropharmacology.

[289]  I. Vetter,et al.  The effects of pH on beta-endorphin and morphine inhibition of calcium transients in dorsal root ganglion neurons. , 2006, The journal of pain : official journal of the American Pain Society.

[290]  S. Hua,et al.  The Neural Cell Adhesion Molecule Antibody Blocks Cold Water Swim Stress-Induced Analgesia and Cell Adhesion Between Lymphocytes and Cultured Dorsal Root Ganglion Neurons , 2006, Anesthesia and analgesia.

[291]  H. Rittner,et al.  Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain , 2006, Journal of leukocyte biology.

[292]  A. Beaudet,et al.  Morphine and Pain-Related Stimuli Enhance Cell Surface Availability of Somatic δ-Opioid Receptors in Rat Dorsal Root Ganglia , 2006, The Journal of Neuroscience.

[293]  S. Schulz,et al.  Pain control by CXCR2 ligands through Ca2+ ‐regulated release of opioid peptides from polymorphonuclear cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[294]  H. Rittner,et al.  Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation , 2006, Neuroscience.

[295]  P. Morley-Forster,et al.  A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008--a long-acting, parenteral opioid analgesic--in the treatment of postherpetic neuralgia. , 2006, Journal of opioid management.

[296]  W. Khan,et al.  CD4+ T-cell modulation of visceral nociception in mice. , 2006, Gastroenterology.

[297]  Á. Meana,et al.  Endogenous β-endorphin induces thermal analgesia at the initial stages of a murine osteosarcoma , 2006, Peptides.

[298]  H. Rittner,et al.  Peripheral Antinociceptive Effects of Exogenous and Immune Cell-Derived Endomorphins in Prolonged Inflammatory Pain , 2006, The Journal of Neuroscience.

[299]  J. Guan,et al.  Role of delivery and trafficking of δ-opioid peptide receptors in opioid analgesia and tolerance , 2006 .

[300]  J. Bos,et al.  Epac proteins: multi-purpose cAMP targets. , 2006, Trends in biochemical sciences.

[301]  A. Stein,et al.  Phosphoinositide 3-Kinase Binds to TRPV1 and Mediates NGF-stimulated TRPV1 Trafficking to the Plasma Membrane , 2006, The Journal of general physiology.

[302]  P. Dubus,et al.  μ-Opioid receptor activation prevents acute hepatic inflammation and cell death , 2007, Gut.

[303]  T. Brennan,et al.  Nerve Growth Factor Expression after Plantar Incision in the Rat , 2007, Anesthesiology.

[304]  S. Milam,et al.  Integrins regulate opioid receptor signaling in trigeminal ganglion neurons , 2007, Neuroscience.

[305]  C. Cahill,et al.  Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain , 2007, Pain.

[306]  R. Straub,et al.  β-Endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis , 2007 .

[307]  Weiguo Zhu,et al.  Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1 , 2007, Molecular and Cellular Neuroscience.

[308]  Misook Kim,et al.  TRPV1 Mediates Histamine-Induced Itching via the Activation of Phospholipase A2 and 12-Lipoxygenase , 2007, The Journal of Neuroscience.

[309]  R. Przewłocki,et al.  Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. , 2007, European journal of pharmacology.

[310]  H. Machelska.  Targeting of opioid-producing leukocytes for pain control , 2007, Neuropeptides.

[311]  Yan-Gang Sun,et al.  A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord , 2007, Nature.

[312]  Graeme Milligan,et al.  G protein-coupled receptor dimerisation: molecular basis and relevance to function. , 2007, Biochimica et biophysica acta.

[313]  R. Likar,et al.  Involvement of Intra-articular Corticotropin-releasing Hormone in Postoperative Pain Modulation , 2007, The Clinical journal of pain.

[314]  W. Maixner,et al.  Effects of carrageenan and morphine on acute inflammation and pain in Lewis and Fischer rats , 2007, Brain, Behavior, and Immunity.

[315]  J. Pin,et al.  Activation of a Dimeric Metabotropic Glutamate Receptor by Intersubunit Rearrangement* , 2007, Journal of Biological Chemistry.

[316]  H. Rittner,et al.  Neurokinin-1 Receptor Antagonists Inhibit the Recruitment of Opioid-containing Leukocytes and Impair Peripheral Antinociception , 2007, Anesthesiology.

[317]  C. Stein,et al.  Relative contribution of peripheral versus central opioid receptors to antinociception , 2007, Brain Research.

[318]  R. Hellweg,et al.  Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. , 2007, Brain : a journal of neurology.

[319]  K. Hargreaves,et al.  Rapid Modulation of μ-Opioid Receptor Signaling in Primary Sensory Neurons , 2007, Journal of Pharmacology and Experimental Therapeutics.

[320]  H. Rittner,et al.  CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo , 2007, Brain, Behavior, and Immunity.

[321]  M. Welte,et al.  Influence of pain treatment by epidural fentanyl and bupivacaine on homing of opioid-containing leukocytes to surgical wounds , 2007, Brain, Behavior, and Immunity.

[322]  J. Puzas,et al.  Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. , 2007, Arthritis and rheumatism.

[323]  Jakub Fichna,et al.  The Endomorphin System and Its Evolving Neurophysiological Role , 2007, Pharmacological Reviews.

[324]  P. Heppenstall,et al.  μ-Opioid Receptor Activation Modulates Transient Receptor Potential Vanilloid 1 (TRPV1) Currents in Sensory Neurons in A Model of Inflammatory Pain , 2007, Molecular Pharmacology.

[325]  M. Angst,et al.  Morphine reduces local cytokine expression and neutrophil infiltration after incision , 2007, Molecular pain.

[326]  L. Huang,et al.  A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2‐induced potentiation of P2X3 receptor currents in inflamed rats , 2007, The Journal of physiology.

[327]  H. Rittner,et al.  Lymphocytes upregulate signal sequence-encoding proopiomelanocortin mRNA and beta-endorphin during painful inflammation in vivo , 2007, Journal of Neuroimmunology.

[328]  L. Gibson,et al.  Effect of Morphine Sulfate on Neonatal Neutrophil Chemotaxis , 2008, The Clinical journal of pain.

[329]  R. Meyer,et al.  Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury , 2008, PAIN.

[330]  F. Liew,et al.  Role of IL-18 in overt pain-like behaviour in mice. , 2008, European journal of pharmacology.

[331]  Z. Sheng,et al.  Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars , 2008, The British journal of dermatology.

[332]  M. Shakibaei,et al.  Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. , 2008, The Journal of clinical investigation.

[333]  A. Mangel,et al.  Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome , 2008, Alimentary pharmacology & therapeutics.

[334]  A. Basbaum,et al.  The senses : a comprehensive reference , 2008 .

[335]  J. Levine,et al.  Proinflammatory cytokines mediating burn-injury pain , 2008, PAIN®.

[336]  R. Straub,et al.  Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. , 2008, Arthritis and rheumatism.

[337]  Steven P. Cohen,et al.  The Effect of Opioid Dose and Treatment Duration on the Perception of a Painful Standardized Clinical Stimulus , 2007, Regional Anesthesia & Pain Medicine.

[338]  H. Rittner,et al.  Immune System, Pain and Analgesia , 2020, The Senses: A Comprehensive Reference.

[339]  R. Houghten,et al.  Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. , 2008, European journal of pharmacology.

[340]  A. Dahan,et al.  Morphine-6-glucuronide: potency and safety compared with morphine , 2008, Expert opinion on pharmacotherapy.

[341]  C. Sen,et al.  Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome. , 2008, Physiological genomics.

[342]  M. Angst,et al.  Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision , 2008, Molecular pain.

[343]  K. Lorenz,et al.  Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. , 2008, Nature chemical biology.

[344]  C. Stein,et al.  Opioids and sensory nerves. , 2009, Handbook of experimental pharmacology.

[345]  K. Ohshima,et al.  Immunohistochemical detection of chemokines in human skin wounds and its application to wound age determination , 2002, International Journal of Legal Medicine.

[346]  C. Stein,et al.  Peripheral mechanisms of opioid analgesia. , 2009, Current opinion in pharmacology.

[347]  E. Bruera,et al.  Textbook of Palliative Medicine , 2009 .

[348]  A. Kopf,et al.  Topical administration of analgesics , 2009 .